NeuroOne Medical Technologies Corporation (NMTC) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for NeuroOne Medical Technologies Corporation, with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | -9.89x | -2.15x | -1.36x | -2.70x | -4.25x | -1.53x |
| P/B Ratio | 5.04x | 32.23x | 2.58x | 2.82x | 6.45x | 10.12x |
| P/S Ratio | 2.95x | 7.67x | 8.26x | 157.96x | 237.18x | 10.85x |
| Profitability | ||||||
| Gross Margin | 67.3% | 31.3% | 23.4% | -41.4% | -54.9% | 96.3% |
| Operating Margin | -34.9% | -344.3% | -612.3% | -5860.2% | -5735.9% | -254.5% |
| Net Margin | -29.8% | -356.7% | -607.4% | -5842.0% | -5584.3% | -708.0% |
| EBITDA Margin | -24.9% | -343.0% | -602.1% | -5790.9% | -5500.0% | -252.0% |
| Liquidity | ||||||
| Current Ratio | 4.44x | 2.09x | 4.08x | 3.93x | 6.17x | 1.76x |
| Quick Ratio | 3.47x | 0.90x | 3.12x | 3.70x | 6.09x | 1.76x |
| Leverage | ||||||
| Debt/Equity | 0.04x | 0.32x | 0.03x | 0.02x | 0.05x | 0.64x |
YoY = year-over-year change. Source: FMP..